RUA Life Sciences plc (AIM:RUA)
19.85
+0.35 (1.79%)
Jun 17, 2026, 10:43 AM GMT
RUA Life Sciences Balance Sheet
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 3.25 | 3.57 | 3.93 | 1.48 | 2.96 |
Cash & Short-Term Investments | 3.25 | 3.57 | 3.93 | 1.48 | 2.96 |
Cash Growth | -8.89% | -9.26% | 164.89% | -49.92% | -52.92% |
Accounts Receivable | 0.73 | 1.09 | 0.3 | 0.18 | 0.22 |
Other Receivables | 0.23 | - | 0.42 | 0.25 | 0.56 |
Receivables | 0.96 | 1.09 | 0.72 | 0.42 | 0.78 |
Inventory | 0.89 | 0.75 | 0.11 | 0.08 | 0.12 |
Prepaid Expenses | 0.29 | - | 0.23 | 0.17 | 0.34 |
Total Current Assets | 5.39 | 5.41 | 4.99 | 2.15 | 4.21 |
Property, Plant & Equipment | 3.07 | 3.17 | 2.46 | 2.74 | 2.6 |
Goodwill | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Other Intangible Assets | 0.35 | 0.38 | 0.42 | 0.47 | 0.52 |
Total Assets | 9.12 | 9.26 | 8.17 | 5.66 | 7.63 |
Accounts Payable | 0.17 | 0.68 | 0.14 | 0.04 | 0.19 |
Accrued Expenses | 0.66 | - | 0.25 | 0.2 | 0.15 |
Current Portion of Long-Term Debt | 0.07 | 0.23 | 0.03 | 0.03 | 0.02 |
Current Portion of Leases | 0.16 | 0.16 | 0.09 | 0.08 | 0.04 |
Current Unearned Revenue | - | - | - | 0.05 | 0.04 |
Other Current Liabilities | 0.1 | 0.03 | 0.04 | 0.01 | 0.07 |
Total Current Liabilities | 1.16 | 1.1 | 0.55 | 0.41 | 0.51 |
Long-Term Debt | - | 0.02 | 0.13 | 0.17 | 0.2 |
Long-Term Leases | 0.56 | 0.62 | 0.14 | 0.2 | 0.08 |
Long-Term Unearned Revenue | - | 0.06 | - | 0.12 | 0.17 |
Long-Term Deferred Tax Liabilities | 0.17 | 0.06 | 0.07 | 0.09 | 0.08 |
Other Long-Term Liabilities | 0.04 | - | 0.09 | - | - |
Total Liabilities | 1.93 | 1.86 | 0.99 | 0.98 | 1.04 |
Common Stock | 3.1 | 3.1 | 3.1 | 1.11 | 1.11 |
Additional Paid-In Capital | 13.71 | 13.71 | 13.71 | 11.73 | 11.73 |
Retained Earnings | -20.2 | -19.98 | -19.99 | -18.55 | -16.54 |
Comprehensive Income & Other | 10.54 | 10.47 | 10.36 | 10.39 | 10.29 |
Total Common Equity | 7.14 | 7.3 | 7.18 | 4.68 | 6.58 |
Minority Interest | 0.04 | 0.09 | - | - | - |
Shareholders' Equity | 7.19 | 7.39 | 7.18 | 4.68 | 6.58 |
Total Liabilities & Equity | 9.12 | 9.26 | 8.17 | 5.66 | 7.63 |
Total Debt | 0.79 | 1.03 | 0.39 | 0.48 | 0.34 |
Net Cash (Debt) | 2.46 | 2.54 | 3.54 | 1.01 | 2.62 |
Net Cash Growth | -3.23% | -28.35% | 251.04% | -61.47% | -55.49% |
Net Cash Per Share | 0.04 | 0.04 | 0.11 | 0.05 | 0.12 |
Filing Date Shares Outstanding | 62.06 | 62.06 | 62.06 | 22.18 | 22.18 |
Total Common Shares Outstanding | 62.06 | 62.06 | 62.06 | 22.18 | 22.18 |
Working Capital | 4.23 | 4.31 | 4.44 | 1.74 | 3.7 |
Book Value Per Share | 0.12 | 0.12 | 0.12 | 0.21 | 0.30 |
Tangible Book Value | 6.5 | 6.62 | 6.46 | 3.91 | 5.76 |
Tangible Book Value Per Share | 0.10 | 0.11 | 0.10 | 0.18 | 0.26 |
Land | 1.99 | - | 1.34 | 1.34 | 1.34 |
Machinery | 2.74 | - | 2.2 | 2.03 | 1.72 |
Construction In Progress | - | - | - | 0.14 | - |